# The Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022, Regulation 12: Amendment of Schedule 1


(1) Schedule 1 (further provisions for classification of medicinal products) is amended as follows.
(2) In Part 1 (descriptions of certain medicinal products to be available only on prescription), in paragraph 1—
(a) omit “and” at the end of sub-paragraph (g);
(b) insert “; and” at the end of sub-paragraph (h); and
(c) after sub-paragraph (h) insert—
“(i) an EAMS medicinal product, in circumstances where the licensing authority has attached a condition to the EAMS scientific opinion in respect of that product to the effect that, for the duration of that opinion, the product is classified as a prescription only medicine.”.
(3) In Part 2 (descriptions of certain medicinal products to be available only from a pharmacy), in paragraph 3—
(a) omit “and” at the end of sub-paragraph (c);
(b) insert “; and” at the end of sub-paragraph (d); and
(c) after sub-paragraph (d) insert—
“(e) an EAMS medicinal product, in circumstances where the licensing authority has attached a condition to the EAMS scientific opinion in respect of that product to the effect that, for the duration of that opinion, it is only to be available from a pharmacy.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2022/9780348231892/regulation/12 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendments-relating-to-the-early-access-to-medicines-scheme-regulations-2022/regulation-12
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

